Keshif Ventures β Full Portfolio
49 tracked investments Β· listed companies and verified rows first
GoShare operates an on-demand marketplace app that connects businesses and consumers with a network of independent delivery professionals driving box trucks, cargo vans, pickup trucks, and cars for last-mile delivery and moving services.
Logistics & Supply ChainMarketplacesMobility & TransportationSan Diego, US
Shaun Savage(Executive Officer, Director)
BoardClaudio Burtin(Director)
Co-investorsXG VenturesAdasel Global Partners LLC
AttackIQ provides automated red team exercise software that scales security testing across organizations without increasing headcount.
CybersecurityEnterprise SoftwareLos Altos, US
Rajesh Sharma(Executive Officer, Director)Brett Galloway(Executive Officer, Director)Danielle Murcray(Executive Officer)
BoardKevin Dillon(Director)Shardul Shah(Director)inBrian Byun(Director)in
Co-investors408 VenturesBeyond CapitalDniproIndex VenturesTitanium VenturesVoyager Capital+3 more
Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.
BiotechDeep TechNew MaterialsSan Diego, US
J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)Michael J. Kamdar(President, Chief Executive Officer and Secretary)
BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)John Nicols(Director)Todd Peterson(Director)
Co-investors11.2 CapitalDCVC (Data Collective)iSelect FundAlexandriaArgonautic VenturesCasdin Capital+1 more
Nanome provides a conversational, AI-assisted platform for exploring molecular structures across web and XR, letting researchers load, build, edit, and score structures using natural language and 300+ scientific tools.
AI & Machine LearningBiotechDeep Tech
Steve McCloskey(Founder)in
Co-investorsBullpen CapitalColopl NextSparkland Capital
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.